Publicacións (119) Publicacións de Diego Santos García

2024

  1. Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real-world data study

    European Journal of Neurology

  2. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

  3. Palliative care management in patients with Parkinson's disease and other movement disorders. National survey to neurologists

    Neurologia, Vol. 39, Núm. 5, pp. 417-425

2023

  1. Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions

    Biomolecules, Vol. 13, Núm. 8

  2. Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness

    Journal of Parkinson's disease, Vol. 13, Núm. 2, pp. 219-231

  3. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

    Neurologia, Vol. 38, Núm. 5, pp. 326-333

  4. Cognitive impairment and dementia in young onset Parkinson’s disease

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812

  5. Depressive Symptoms and Their Impact on Quality of Life in Parkinson’s Disease: An Exploratory Network Analysis Approach

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  6. Expanded and Independent Spanish Validation of the MDS-Non Motor Rating Scale

    Movement Disorders Clinical Practice, Vol. 10, Núm. 4, pp. 586-595

  7. Falls Predict Acute Hospitalization in Parkinson's Disease

    Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124

  8. How can I assess my patients with Parkinson's disease during a busy clinic day?

    Parkinsonism and Related Disorders, Vol. 114

  9. Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group

    Parkinson's Disease, Vol. 2023

  10. Protocolo diagnóstico diferencial de los síndromes parkinsonianos

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 76, pp. 4536-4539

  11. Response to levodopa in Parkinson's disease over time. A 4-year follow-up study

    Parkinsonism and Related Disorders, Vol. 116

  12. Risk of Cognitive Impairment in Patients With Parkinson’s Disease With Visual Hallucinations and Subjective Cognitive Complaints

    Journal of Clinical Neurology (Korea), Vol. 19, Núm. 4, pp. 344-357

  13. STAT-ON™: The holter for parkinson's disease motor symptoms. Real use cases in clinical praxis

    A Holter for Parkinson's Disease Motor Symptoms: STAT-ON™ (River Publishers), pp. 151-206

  14. Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson’s Disease

    Journal of Clinical Medicine, Vol. 12, Núm. 4

  15. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

  16. Suicidal ideation among people with Parkinson's disease and comparison with a control group

    International journal of geriatric psychiatry, Vol. 38, Núm. 5, pp. e5919

  17. The Impact of Nonmotor Symptoms on Health-Related Quality of Life in Parkinson’s Disease: A Network Analysis Approach

    Journal of Clinical Medicine, Vol. 12, Núm. 7